LIM
REGN icon

Lagoda Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Lagoda Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-146
Closed -$55K – 28
2018
Q4 		$55K Sell
146
-57,285
-100% -$21M 0.09% 25
2018
Q3 		$23.2M Sell
57,431
-2,547
-4% -$969K 9.7% 2
2018
Q2 		$20.7M Sell
59,978
-6,682
-10% -$2.09M 8.6% 2
2018
Q1 		$23M Buy
66,660
+2,282
+4% +$794K 8.66% 2
2017
Q4 		$24.2M Buy
64,378
+8,661
+16% +$3.51M 9.22% 2
2017
Q3 		$24.9M Buy
55,717
+1,285
+2% +$611K 9% 2
2017
Q2 		$26.7M Sell
54,432
-14,701
-21% -$6.43M 10.21% 2
2017
Q1 		$26.8M Sell
69,133
-3,884
-5% -$1.44M 10.4% 2
2016
Q4 		$26.8M Sell
73,017
-114
-0.2% -$43.4K 9.2% 3
2016
Q3 		$29.4M Buy
73,131
+393
+0.5% +$158K 8.84% 2
2016
Q2 		$25.4M Sell
72,738
-1,578
-2% -$608K 9.47% 2
2016
Q1 		$26.8M Sell
74,316
-25,613
-26% -$10.6M 8.77% 2
2015
Q4 		$54.2M Buy
99,929
+181
+0.2% +$98.1K 14.38% 1
2015
Q3 		$46.4M Sell
99,748
-407
-0.4% -$219K 13.54% 1
2015
Q2 		$51.1M Buy
100,155
+4,666
+5% +$2.28M 13.39% 1
2015
Q1 		$43.1M Buy
95,489
+3,218
+3% +$1.36M 11.53% 1
2014
Q4 		$37.9M Buy
+92,271
New +$36.3M 10.1% 1

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lagoda Investment Management's REGN Position: Q1 2019 in Review

Lagoda Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2019, closing a stake of 146 shares — an estimated $55K sold.

Lagoda Investment Management first reported a position in REGN in Q4 2014 and held it in 17 quarters. The position peaked at $54.2M in Q4 2015. 719 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

  • Lagoda Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Lagoda Investment Management sold 146 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $55K.
  • Lagoda Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Lagoda Investment Management's Regeneron Pharmaceuticals position peaked at $54.2M in Q4 2015.
  • 719 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Lagoda Investment Management's 13F filing for Q1 2019, filed 15 May 2019.